Literature DB >> 18312759

Comparison of prevalence of >70% diameter narrowing of one or more major coronary arteries in patients with versus without mitral annular calcium and clinically suspected coronary artery disease.

Hari Kannam1, Wilbert S Aronow, Kiran Chilappa, Tarunjit Singh, John A McClung, Anthony L Pucillo, Melvin B Weiss, Kumar Kalapatapu, Thomas Sullivan, Craig E Monsen.   

Abstract

The prevalence of >70% narrowing of 1, 2, or 3 major coronary arteries and of 3 major coronary arteries was investigated in 2,465 patients (1,437 men, 1,028 women; mean age 69 +/- 13 years) with severe, moderate, mild, or no mitral annular calcium (MAC) diagnosed by 2-dimensional echocardiography who underwent coronary angiography for suspected coronary artery disease. Greater than 70% narrowing of 1, 2, or 3 major coronary arteries was present in 259 of 315 patients (82%) with severe MAC (group 1), in 835 of 1,052 patients (79%) with moderate or mild MAC (group 2), and in 756 of 1,098 patients (69%) with no MAC (group 3) (p <0.001 comparing group 1 with group 3 and group 2 with group 3). Greater than 70% narrowing of 3 major coronary arteries was present in 149 of 315 patients (47%) in group 1, in 366 of 1,052 patients (35%) in group 2, and in 325 of 1,098 patients (30%) in group 3 (p <0.001 comparing group 1 with group 3 and group 1 with group 2; p <0.01 comparing group 2 with group 3). In conclusion, MAC is associated with obstructive >or=1-vessel coronary artery disease and with obstructive 3-vessel coronary artery disease.

Entities:  

Mesh:

Year:  2007        PMID: 18312759     DOI: 10.1016/j.amjcard.2007.09.108

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  1 in total

1.  Cardiac calcium score on 2D echo: correlations with cardiac and coronary calcium at multi-detector computed tomography.

Authors:  Nicola Gaibazzi; Chiara Baldari; Pompilio Faggiano; Lisa Albertini; Giacomo Faden; Filippo Pigazzani; Cristina Rossi; Claudio Reverberi
Journal:  Cardiovasc Ultrasound       Date:  2014-10-28       Impact factor: 2.062

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.